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In Brief
b-neurexins have a surprisingly distinct
and selective role in regulating
neurotransmitter release in the
hippocampus and in maintaining
conceptual fear memories. They act to
trans-synaptically downregulate tonic
endocannabinoid signaling, whose
presence at excitatory hippocampal
neurons was unexpected.
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a- and b-neurexins are presynaptic cell-adhesion
molecules implicated in autism and schizophrenia.
We find that, although b-neurexins are expressed
at much lower levels than a-neurexins, conditional
knockout of b-neurexins with continued expression
of a-neurexins dramatically decreased neurotrans-
mitter release at excitatory synapses in cultured
cortical neurons. Theb-neurexin knockoutphenotype
was attenuated by CB1-receptor inhibition, which
blocks presynaptic endocannabinoid signaling, or
by 2-arachidonoylglycerol synthesis inhibition, which
impairs postsynaptic endocannabinoid release. In
synapses formed by CA1-region pyramidal neurons
onto burst-firing subiculum neurons, presynaptic
in vivo knockout ofb-neurexins aggravated endocan-
nabinoid-mediated inhibition of synaptic transmis-
sion and blocked LTP; presynaptic CB1-receptor
antagonists or postsynaptic 2-arachidonoylglycerol
synthesis inhibition again reversed this block. More-
over, conditional knockout of b-neurexins in CA1-
region neurons impaired contextual fear memories.
Thus, our data suggest that presynaptic b-neurexins
control synaptic strength in excitatory synapses by
regulating postsynaptic 2-arachidonoylglycerol syn-
thesis, revealing an unexpected role for b-neurexins
in the endocannabinoid-dependent regulation of neu-
ral circuits.INTRODUCTION
Synaptic cell-adhesion molecules play critical roles in estab-
lishing and restructuring synaptic connections throughout life.
Neurexins are evolutionarily conservedpresynaptic cell-adhesion
molecules that engage in trans-synaptic interactions with multi-
farious postsynaptic ligands, including neuroligins (NLs), cere-
bellins, and LRRTMs (Krueger et al., 2012; Su¨dhof, 2008). Inmammals, neurexins are encoded by three genes, each of which
contains independent promoters for longer a- and shorter b-neu-
rexins (Rowen et al., 2002; Tabuchi and Su¨dhof, 2002; Ullrich
et al., 1995; Ushkaryov et al., 1992, 1994). b-neurexins are
N-terminally truncated versions of a-neurexins that contain only
a short (40 residues) b-specific N-terminal sequence that then
splices into the middle of the a-neurexin sequences (Ushkaryov
et al., 1992). a- and shorter b-neurexin transcripts are extensively
alternatively spliced at six canonical sites, resulting in over 1,000
distinct neurexinmRNAs (Ullrichet al., 1995;Treutlein et al., 2014).
Although neurexins are well studied, little is known about their
fundamental functions. Ligands that bind to either both a- and
b-neurexins (e.g., neuroligins, LRRTMs, dystroglycan, and cere-
bellins; Ichtchenko et al., 1995, Ko et al., 2009; de Wit et al.,
2009; Siddiqui et al., 2010, Uemura et al., 2010) or only to a-neu-
rexins (e.g., neurexophilins; Petrenko et al., 1996) have been
described, and constitutive knockouts (KOs) of a-neurexins
were shown to severely impair neurotransmitter release (Missler
et al., 2003). However, only a limited understanding of a-neurexin
functions is available, and little is known about b-neurexins. The
lack of information on b-neurexin functions is particularly striking
because nearly all biochemical studies on neurexins were
performed with b-neurexins. Elucidating the synaptic actions of
neurexins is a major technical challenge given their diversity
and complexity. This challenge has taken on added importance
given that hundreds of neurexin mutations were associated with
several neuropsychiatric disorders (Su¨dhof, 2008; Bang and
Owczarek, 2013; Clarke and Eapen, 2014).
To specifically assess the function of b-neurexins, we gener-
ated mutant mice carrying conditional KO (cKO) alleles of all
three b-neurexins. Despite a low abundance of b-neurexin tran-
scripts, we found that KO of b-neurexins in cultured neurons
in vitro and in hippocampus in vivo impaired neurotransmitter
release at excitatory synapses. Surprisingly, this decrease
was due, at least in part, to enhanced tonic activation of presyn-
aptic CB1-receptors (CB1Rs), caused by increased postsyn-
aptic synthesis of the endocannabinoid 2-arachidonoylglycerol
(2-AG).Moreover, synapses of hippocampal CA1 pyramidal cells
onto pyramidal neurons in the subiculum—the major output
pathway of the hippocampus—were differentially regulated
by endocannabinoids, and deletion of b-neurexins selectivelyCell 162, 593–606, July 30, 2015 ª2015 Elsevier Inc. 593
Figure 1. Conditional KO of b-Neurexins
Impairs Excitatory Synaptic Transmission
(A) b-neurexins are expressed at levels 10- to
100-fold lower than those of a-neurexins. Data
show relative a- and b-neurexin mRNA levels
measured by qRT-PCR (n = 3 mice at P30).
(B) Conditional KO (cKO) strategy for neurexin-
1b (left) and neurexin-2b and -3b (right, dashed
box). All cKOs involve floxing the 50 b-neurexin-
specific exon and adding an N-terminal epitope
tag (EGFP for neurexin-1b and -3b; HA-tag for
neurexin-2b).
(C) Immunoblots of tagged b-neurexins in cKO
mice with antibodies to GFP (top) and to a
conserved C-terminal neurexin epitope (bottom).
Proteins in cortex homogenates (from 3-week-old
control and triple-b-neurexin cKO mice; input)
were immunoprecipitated with GFP antibodies
(GFP-IP) to visualize the low-abundance b-neu-
rexins in cKO mouse samples.
(D) b-neurexin KO does not alter morphological
parameters in cultured cortical neurons. (Left)
Representative images of neurons filled with Alexa
Fluor 594 via the patch pipette. (Right) Summary
graphs of spine density.
(E) b-neurexin KO does not impair excitatory
synapse density and size. (Left) Representative
images; (right) summary graphs of vGlut1-positive
synapse density.
(F–H) b-neurexin KO in cultured cortical neurons
impairs excitatory, but not inhibitory, synaptic
transmission evoked by isolated action potentials
(F, AMPAR-mediated EPSCs; G, NMDAR-medi-
ated EPSCs; H, GABAR-mediated IPSCs).
(I) b-neurexin KO decreases the presynaptic
release probability, measured via the MK-801-
induced progressive block of NMDAR-mediated
synaptic responses. (Left) Representative EPSC
traces for the 1st, 10th, 25th, and 125th stimulus.
(Center) Mean ESPC amplitudes. (Right) Summary
graphs of decay constants.
(J) b-neurexin KO does not alter the readily
releasable vesicle pool as analyzed by stimulation
with 0.5 M sucrose. (Left) Representative traces.
(Right) Total charge transfer.
Data in (D)–(J) are means ± SEM (numbers of
neurons/independent cultures examined are
shown in graphs). Statistical analyses were
performed by Student’s t test (*p < 0.05; **p < 0.01;
***p < 0.001).
See also Figures S1, S2, S3, and S4.impaired the function of the more strongly endocannabinoid-
regulated synapses in the subiculum. The importance of this
circuit-specific synaptic alteration emerged from behavioral
studies, showing that the b-neurexin KO in the adult CA1
region produced an impairment of contextual fear memory.
Thus, b-neurexins are produced as minor transcripts of neurexin
genes that nevertheless are essential for the regulation of
mammalian synaptic circuits due to modulation of endocannabi-
noid signaling via an unanticipated trans-synaptic mechanism.594 Cell 162, 593–606, July 30, 2015 ª2015 Elsevier Inc.RESULTS
Generation of b-Neurexin-Specific Conditional
Triple-KO Mice
Using qRT-PCR, we found that throughout the brain, all three
b-neurexins were expressed at levels 10- to 100-fold lower than
are corresponding a-neurexins (Figures 1A and S1). Despite their
low abundance, however, b-neurexins are highly conserved and
might still perform essential functions. To test this hypothesis, we
generated conditional and constitutive KOmice of all b-neurexin
genes (Figures 1B and S2A–S2C). In these mice, the 50 exon that
encodes the N-terminal b-neurexin-specific sequences was
flanked by loxP sites, and epitope tags were inserted into the
b-neurexin-specific sequences (EGFP for neurexin-1b and -3b;
a hemagglutinin [HA] tag for neurexin-2b). We generated single-,
double-, and triple-conditional and constitutive b-neurexin KO
mice (see the Experimental Procedures for details) and focused
our analyses on triple-mutant mice, targeting all b-neurexins to
brace for potential redundancies among b-neurexins.
Conditional triple KO (cKO) mice were viable and fertile. The
EGFP and HA tags did not alter expression of either a- or b-neu-
rexin mRNAs (Figures S2D and S2E). Probably because of their
low expression levels, tagged b-neurexins could not be detected
in total brain extracts, but were readily observed after immuno-
precipitations of b-neurexins with EGFP antibodies (Figure 1C).
Constitutive triple-b-neurexin KO mice were also viable but
were significantly smaller than wild-type mice and unable to
reproduce (Figure S2F). Even single-neurexin-2b and -3b KO
mice exhibited a significantly reduced body weight. Thus, b-neu-
rexins—despite low abundance and in contrast to a-neurexins
(Missler et al., 2003)—are important for animal health but are
not essential for animal survival.
Conditional b-Neurexin KO Impairs Neurotransmitter
Release at Excitatory Synapses
We cultured cortical neurons from triple-b-neurexin cKO mice
and infected them with lentiviruses expressing active (Cre; to
delete all b-neurexins) or inactive, truncated Cre-recombinase
(DCre; as a control). b-neurexin KO neurons exhibited no change
in dendritic arborization or synaptic morphology, suggesting
normal neuronal development (Figures 1D, 1E, S3, and S4A–
S4E). We evoked action potential-induced excitatory and inhib-
itory postsynaptic currents (EPSCs and IPSCs, respectively;
Kaeser et al., 2011) and separately monitored pharmacolog-
ically isolated AMPA-receptor (AMPAR)- and NMDA-receptor
(NMDAR)-mediated EPSCs and GABA-receptor (GABAR)-
mediated IPSCs. Strikingly, the b-neurexin KO decreased both
AMPAR- and NMDAR-mediated EPSCs by 50%, but had no
effect on GABAR-mediated IPSCs (Figures 1F–1H).
These results suggest that the b-neurexin KO caused a
decrease in the probability of glutamate release at excitatory
synapses. To directly test this hypothesis, we measured presyn-
aptic release probability using the progressive use-dependent
block of evoked NMDAR EPSCs by MK-801 (Hessler et al.,
1993; Rosenmund et al., 1993). We observed in triple-b-neurexin
KO neurons a robust, 2-fold decrease in the rate of synaptic
NMDAR inactivation in the presence of MK-801, suggesting an
2-fold decrease in release probability (Figure 1I). This decrease
was not due to a change in the readily releasable pool of synaptic
vesicles because the b-neurexin deletion had no effect on hyper-
tonic sucrose-evoked EPSCs (Figure 1J).
b-Neurexin KO Impairs Action Potential-Induced Ca2+
Influx into Presynaptic Terminals
The electrophysiological data suggest that b-neurexins are
required for normal coupling at excitatory synapses of an action
potential to Ca2+-triggered release, possibly because voltage-gated Ca2+ influx is impaired. To test this hypothesis, we con-
structed a chimeric protein (GCaMP5G-Syb2) containing an
N-terminal GCaMP5G Ca2+ indicator fused to the synaptic
vesicle protein synaptobrevin-2 (Figure 2A). After lentiviral
expression in neurons, GCaMP5G-Syb2 was efficiently targeted
to presynaptic terminals (Figure 2B). To restrict analyses of
presynaptic Ca2+ transients to excitatory synapses, we sparsely
transfected neurons with mCherry and monitored action poten-
tial-elicited Ca2+ transients only in presynaptic boutons contact-
ing postsynaptic dendritic spines (Figure 2B). Electrical-field
stimulation (1–100 stimuli at 50 Hz) elicited robust Ca2+-induced
fluorescence signals in these boutons that saturated after 20
stimuli, consistent with accumulation of residual Ca2+ in presyn-
aptic terminals during stimulus trains (Figures 2B and 2C). Ca2+
signals were blocked by tetrodotoxin (TTX), confirming that
they were induced by action potential-stimulated Ca2+ influx.
For analyses, we normalized the Ca2+-induced fluorescence sig-
nals to the maximal fluorescence change induced by 100 stimuli
(DFsat), which saturates the GCaMP5G-Syb2 Ca
2+ sensor.
We then used GCaMP5G-Syb2 to analyze Ca2+ transients in
b-neurexin KO and control neurons. Ca2+ influx was induced
by 1–10 action potential stimuli in the linear range of our Ca2+
sensor (Figure 2C). We found that KO of b-neurexins significantly
attenuated action potential-induced Ca2+-transients, with an
overall2-fold decrease (Figures 2D and 2E). KO of b-neurexins
had no effect on presynaptic levels of voltage-gated N- or P/Q-
type Ca2+-channels, suggesting a functional impairment (Figures
2F and S4F–S4H).
Viewed together, these data show that the b-neurexin KO
causes a 2-fold decrease in three excitatory synapse parame-
ters: EPSC amplitude, release probability, and action-potential-
induced Ca2+ influx. This suggests that b-neurexins, despite their
lowabundancecompared toa-neurexins, are selectively essential
for normal action-potential gated Ca2+ influx during neurotrans-
mitter release at excitatory synapses.
b-Neurexin KO Decreases Spontaneous Mini Release at
Excitatory Synapses: Selective Rescue by Neurexin-1b
Lacking an Insert in SS4
Neurotransmitter release occurs at synapses not only in
response to action potentials but also as spontaneous miniature
EPSCs (mEPSCs) or miniature IPSCs (mIPSCs) that are largely
dependent on intracellular Ca2+ (Xu et al., 2009). The b-neurexin
KO substantially depressed the mEPSC frequency (2-fold),
slightly decreased the mEPSC amplitude, and lowered the sur-
face levels of GluA1 AMPARs (Figures 3A, 3B, S4I, and S4J).
However, b-neurexin KO had no effect on mIPSC frequency
and amplitude (Figures 3C and 3D), consistent with the selective
suppression of the presynaptic release probability by the b-neu-
rexin KO in excitatory, but not in inhibitory, synapses.
To validate the specificity of the b-neurexin KO effects on
neurotransmitter release, we used ‘‘mini’’ release as a measure
of release probability and tested the ability of neurexin-1b
containing or lacking an insert in splice site #4 (SS4) and of neu-
rexin-1a lacking an insert in SS4 to rescue the phenotype. Only
neurexin-1b lacking an insert in SS4 rescued the decrease in
excitatory synaptic transmission in b-neurexin KO neurons
(Figures 3E and 3F). Neurexin-1b lacking an insert in SS4 alsoCell 162, 593–606, July 30, 2015 ª2015 Elsevier Inc. 595
Figure 2. Conditional KO of b-Neurexins Impairs Presynaptic Ca2+
Influx
(A) Design of Ca2+ imaging experiments. (Left) Schematic of the GCaMP5G-
Syb2 fusion protein that acts as a presynaptic Ca2+ probe; (Right) Flow
diagram of experiments.
(B) Representative Ca2+ imaging experiments. (Left) Sample images of pre-
synaptic boutons containing GCaMP5G-Syb2 (green) that contact mCherry-
containing dendritic spines (red; images were obtained before and after
maximal stimulation to saturate Ca2+ transients [DFsat]; white circles, regions of
interest [ROIs] for quantitative analysis by line scans [arrows]). (Right) Sum-
mary graphs of line scans through ROIs at before (top) and after maximal
stimulation (DFsat; bottom; green, presynaptic Ca
2+ concentration; red, post-
synaptic mCherry signal).
(C) Presynaptic Ca2+ transients saturate after 20 stimuli and are blocked
by TTX. (Left) Representative Ca2+ transients. (Right) Summary graphs (TTX,
n = 12 neurons; +TTX, n = 2 neurons).
(D) b-neurexin KO impairs action potential-induced presynaptic Ca2+ influx in
cultured cortical neurons (DCre = control; Cre = KO). (Left) Representative
fluorescence traces of ten stimuli applied at 50 Hz. (Right) Scatter plots of
individual bouton responses to 1, 5, and 10 stimuli.
596 Cell 162, 593–606, July 30, 2015 ª2015 Elsevier Inc.enhanced mEPSC amplitude, probably because this neurexin
splice variant stabilizes postsynaptic AMPARs (Aoto et al.,
2013). The SS4-dependent rescue of the triple-b-neurexin KO
phenotype not only validates its overall specificity but also sug-
gests that b-neurexins control synaptic strength via a specific
interaction with postsynaptic ligands that do not bind to a-neu-
rexins. Alternative splicing at SS4 dramatically influences neu-
rexin binding to postsynaptic ligands (Boucard et al., 2005;
Chih et al., 2006; Ko et al., 2009; Siddiqui et al., 2010; Uemura
et al., 2010; Matsuda and Yuzaki, 2011). Indeed, we observed
that at least some neuroligin-1 splice variants specifically bind
only to b-neurexins, but not to a-neurexins lacking an insert in
SS4 (Figure S5I).
b-Neurexin KO Enhances Basal Endocannabinoid
Activity
How might deletion of b-neurexins influence presynaptic Ca2+
influx? A hint derives from the synaptic dysfunction caused by
the neuroligin-3 KO, a postsynaptic cell-adhesion molecule that
binds to presynaptic neurexins (Su¨dhof, 2008). In CA1 pyramidal
neurons, the neuroligin-3 KO decreases tonic endocannabinoid
signaling, mediated by cannabinoid receptor type 1 (CB1R), at
inhibitory synapses from CCK-positive basket neurons, thereby
increasing GABA release (Fo¨ldy et al., 2013). This observation
led us to ask whether the b-neurexin KO might cause the oppo-
site change at excitatory synapses, i.e., an increase in basal
endocannabinoid signaling, that could account for the decrease
in Ca2+ influx and neurotransmitter release in b-neurexin KO
synapses.
We tested the effect of the CB1R antagonist AM251 on
mEPSCs, again used as a measure of presynaptic release prob-
ability. AM251 had no effect on the mEPSC amplitude or fre-
quency in control neurons (Figures 3G and S5A–S5D). However,
AM251 significantly enhanced the mEPSC frequency without
changing the mEPSC amplitude in b-neurexin KO neurons
(Figures 3G and S5A–S5D), suggesting that KO of b-neurexins
enhances basal endocannabinoid tone.
To further explore this hypothesis, we examined the effects of
the CB1R agonist WIN (WIN55,212-2 mesylate) on mEPSCs.
While WIN produced a similar relative decrease in mEPSC fre-
quency in triple-b-neurexin KO and control neurons (Figure S5G),
we observed a significantly smaller absolute decrease inmEPSC
frequency in KO neurons (Figures 3H andS5H). This observation,
consistent with the findings from the AM251 experiments, sug-
gests that in b-neurexin KO synapses, CB1Rs are partially acti-
vated, and thus less additional inhibition is induced by WIN.
Together, these data indicate that the b-neurexin KO caused an(E) Summary plot of mean Ca2+ transients after 1, 5, and 10 stimuli. (Left) n = 3
independent experiments with 2–4 boutons per neuron. (Right) Summary
graph of the mean linear slopes fitted through the 1, 5, and 10 stimuli plots.
(F) b-neurexin KO does not alter levels or localization of presynaptic Ca2+
channels (representative images of cortical pyramidal neuron spines
with sparse GFP expression that are stained for presynaptic P/Q-type
[CaV2.1] or N-type [CaV2.2] Ca2+ channels). For quantitative analyses, see
Figures S4F–S4H.
Data are means ± SEM. Statistical analysis was performed by Student’s t test
(*p < 0.05; **p < 0.01).
See also Figure S4.
Figure 3. Neurexin-1b, but Not Neurexin-1a, and the CB1R Antago-
nist AM251 Rescue Impaired Spontaneous Mini Release in b-Neu-
rexin KO Neurons
(A–D) b-neurexin KO impairs mini release at excitatory, but not inhibitory,
synapses (A and B, mESPCs; C and D, mIPSCs) in cortical neurons from triple-
b-neurexin cKO mice expressing inactive (DCre) or active Cre-recombinase
(Cre). (A and C) Representative traces (left), cumulative distributions of inter-
event intervals (right), and mean event frequencies (inset). (B and D) Average
individual events (left), cumulative distributions of event amplitudes (right), and
mean event amplitudes (inset).
(E) Neurexin-1b without an insert in SS#4 (–SS4), but not with an insert (+SS4),
rescues the decreased mEPSC frequency in b-neurexin KO neurons.
(F) Neurexin-1a without an insert in SS#4 (–SS4) fails to rescue the decreased
mEPSC frequency in b-neurexin KO neurons.
(G) Blocking CB1Rswith AM251 reverses the decrease in mEPSC frequency in
b-neurexin KO neurons. (Left) Representative traces. (Center) Cumulativeincrease in the basal activity of presynaptic CB1Rs, which are
known to inhibit presynaptic Ca2+ channels and to decrease
neurotransmitter release (Twitchell et al., 1997; Kreitzer and Re-
gehr, 2001; Brown et al., 2004; Szabo´ et al., 2014). Consistent
with observations on neuroligin-3 (Fo¨ldy et al., 2013), these
data reveal a connection of the neurexin/neuroligin complex to
endocannabinoid signaling. Thedirectionof theeffects, however,
is diametrically opposite: whereas the b-neurexin KOsuppresses
the presynaptic neurotransmitter release probability at excitatory
synapses, the neuroligin-3 KO increases release at inhibitory
synapses.
Conditional b-Neurexin KO Increases Postsynaptic 2-AG
Synthesis
To begin to explore how the b-neurexin KO increases the basal
endocannabinoid ‘‘tone’’ at excitatory synapses, we examined
CB1R levels in b-neurexin KO neurons by immunoblotting and
immunocytochemistry. We detected no changes, suggesting
that presynaptic b-neurexins may influence endocannabinoid
synthesis, which is postsynaptic (Figures 4A–4D; Murataeva
et al., 2014, Castillo et al., 2012, Di Marzo et al., 2004). To test
which of the brain’s two major endocannabinoids—2-AG and
anandamide—is active at the synapses that are affected by the
b-neurexin KO, we measured the effects of exogenous 2-AG
and anandamide on mEPSCs in control and b-neurexin KO
neurons.
Bath-applied anandamide had only a modest effect on
mEPSCs in cultured cortical neurons, with no significant differ-
ence between control and b-neurexin KO neurons. In contrast,
2-AG robustly suppressedmEPSC frequency in control neurons,
but not in b-neurexin KOneurons (Figures 4E and 4F). This obser-
vation, consistent with the findings from the AM251 andWIN ex-
periments (Figures 3G and 3H), suggests that the b-neurexin KO
partially activates CB1Rs by increasing basal levels of 2-AG,
which prevents the additional inhibition by exogenous 2-AG.
Anandamide is likely relatively inactive because it is a partial
agonist andmay not primarily act via CB1Rs (Freund et al., 2003).
2-AG is synthesized via a postsynaptic phospholipase
C-dependent pathway (Figure 4A). To test whether postsynaptic
2-AG synthesis may be upregulated upon loss of presynaptic
b-neurexins, we blocked phospholipase C-dependent 2-AG
synthesis specifically in postsynaptic neurons by introducing
the phospholipase C inhibitor U73122 via the patch pipette into
postsynaptic neurons. U73122 had only minimal effects in con-
trol neurons, but caused full rescue of the mEPSC frequency in
b-neurexin KO neurons (Figure 4G).
Together, thesedata suggest that increasedpostsynaptic2-AG
synthesis produces thepresynapticb-neurexinKOphenotype. Todistributions of event frequencies with insets showing mean frequencies;
(Right) Summary graphs of AM251-induced changes.
(H) Activating CB1Rs with WIN (WIN 55,212-2 mesylate) depresses mini
release significantly more in control (DCre) than in b-neurexin KO neurons
(Cre). The figure design is analogous to that of (G).
Data are means ± SEM; the numbers of neurons/independent cultures
examined are shown in the graphs. Statistical analyses were performed using
Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001).
See also Figures S4 and S5.
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Figure 4. Blocking Postsynaptic 2-AG Synthesis Rescues Presynaptic b-Neurexin KO Phenotype in Cultured Neurons
(A) A diagram of endocannabinoid signaling pathways. Two distinct endocannabinoids (2-arachidonoylglycerol [2-AG] and anandamide [AEA, N-arach-
idonoylethanolamine]) are synthesized by different postsynaptic enzymes; both act on presynaptic CB1Rs (PLC, phospholipase C; PIP2, phosphatidylinositol
4,5-bisphosphate; DAG, diacylglycerol; DAGL, diacylglycerol lipase; NAT, N-acyltransferase; PE, phosphatidylethanolamine; NAPE, N-arachidonoyl phos-
phatidylethanolamine; PLD, phospholipase D). Modes of action of the 2-AG synthesis inhibitor U73122 and the CB1R agonist WIN and antagonist AM251 are
indicated.
(legend continued on next page)
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consolidate this conclusion, we assayed the state of CB1Rs as
a function of postsynaptic 2-AG synthesis inhibition. We bath-
applied the CB1R-antagonist AM251 (Figure 4H) or the CB1R-
agonist 2-AG (Figure 4I), while recording from postsynaptic
neurons containing the 2-AG synthesis inhibitor U73122.
U73122eliminated theenhancedbasal activityofCB1Rs inb-neu-
rexin KO neurons (Figures 3G and 4H) and restored the sensitivity
of CB1Rs to exogenous 2-AG (Figures 4F and 4I). Thus, postsyn-
aptic inhibition of 2-AG synthesis in b-neurexin KO neurons
restores the signaling set-point of presynaptic CB1Rs to that
observed in control neurons, confirming that b-neurexins activate
presynaptic CB1Rs via an upregulation of postsynaptic 2-AG
synthesis.
Conditional b-Neurexin KO In Vivo Suppresses Release
at Hippocampal Output Synapses
Modulation of endocannabinoid signaling by b-neurexins would
have significant circuit implications and could be relevant not
only for understanding abnormalities of circuit dynamics in
neuropsychiatric disorders but also for possible future therapeu-
tic options. Thus, we tested whether b-neurexins also control
endocannabinoid signaling in vivo.
We stereotactically injected AAVs encoding Cre-EGFP or
DCre-EGFP into the hippocampal CA1 region of triple-b-neu-
rexin cKO mice at P21 and analyzed acute subiculum slices at
P35–P40 (Figure 5A). We monitored synaptic transmission at
synapses formed by CA1-region axons onto pyramidal neurons
of the subiculum, which is the major output pathway of the
hippocampus. In this approach, only presynaptic neurons are
genetically manipulated (Aoto et al., 2013). Pyramidal subiculum
neurons comprise two broad classes—‘‘regular-firing’’ and
‘‘burst-firing’’ neurons—that can be readily distinguished by
the pattern of action potentials induced by current injections
(Figure 5B; Graves et al., 2012; Staff et al., 2000; van Welie
et al., 2006). All analyses were performed separately in these
two classes of neurons. Upon whole-cell break-in, we identified
the neuron type in current-clamp mode and then recorded
EPSCs induced by stimulating CA1-region axons in voltage-
clamp mode (Figure 5B).
We assessed excitatory synaptic strength by measuring the
input-output relationship (Figures 5C and 5D). In regular-firing
neurons, the b-neurexin KO produced a trend toward decreased
synaptic strength (Figure 5C). In burst-firing neurons, however,
the b-neurexin KO caused a 2-fold decrease in synaptic(B–D) CB1R levels are similar in cortical neurons from triple-b-neurexin cKOmice
immunoblots with antibodies to CB1R, CaV2.1, and CaV2.2 Ca2+ channels, GluR
quantifications of CB1R levels (C) and CB1R localization (D). Note that neurons w
(E and F) 2-AG causes a larger depression of mini release in control than in b-neure
partial agonist (F). (Left) Representative traces. (Center) Cumulative distributions
graphs of anandamide- or 2-AG-induced changes.
(G) Selective postsynaptic block of 2-AG synthesis by U73122 in the patch pipette
setup and representative mEPSC traces. (Right) Bar diagrams of mEPSC freque
(H and I) Selective postsynaptic block of 2-AG synthesis by U73122 prevents CB
bath-applied AM251 (H) or activating CB1Rs with bath-applied 2-AG (I). (Left) R
intervals (insets = mean frequencies). (Right) Summary graphs of AM251- or 2-A
Data are means ± SEM; the numbers of neurons/independent cultures examined
**p < 0.01, ***p < 0.001).
See also Figure S5.strength, similar to cultured cortical neurons (Figure 5D). More-
over, we measured paired-pulse ratios (PPRs) that inversely
correlate with the presynaptic release probability (Kaeser and
Regehr, 2014). Again, the presynaptic b-neurexin KO caused
no change in regular-firing neurons (Figure 5E), but increased
the PPR in burst-firing neurons, consistent with a decrease in
release probability (Figure 5F). Thus, the presynaptic b-neurexin
KO selectively decreases neurotransmitter release in burst-firing
neuron synapses.
b-Neurexins Control Endocannabinoid Regulation of
Subiculum Synapses
Does the presynaptic b-neurexin KO impair neurotransmitter
release in burst-firing subiculum neuron synapses by an endo-
cannabinoid-dependent mechanism similar to cultured cortical
neurons? To address this question, we first needed to learn
whether tonic endocannabinoid signaling normally regulates
release at subiculum synapses. Bath application of the CB1R
antagonist AM251 had no effect on EPSC amplitudes in
regular-firing neurons, but caused a significant enhancement
of EPSCs in burst-firing neurons (Figure 5G). Bath application
of the CB1R agonist WIN, conversely, induced amodest depres-
sion of EPSCs in regular-firing neurons but a significantly stron-
ger depression of EPSCs in burst-firing neurons (Figure S6A).
Thus, endocannabinoids tonically modulate excitatory synapses
formed onto burst-firing neurons and perform a smaller role at
synapses formed onto regular-firing neurons.
Next, we explored whether the b-neurexin KO decreases
neurotransmitter release in burst-firing neuron synapses by
increasing basal endocannabinoid tone. To this end, we bath-
applied AM251 to subiculum slices without or with presynaptic
KO of b-neurexins. Presynaptic b-neurexin KO caused a signifi-
cant increase in the AM251-dependent enhancement of EPSCs
(Figure 5H), suggesting that similar to cultured neurons in vitro
(Figure 3G), the b-neurexin KO increased endocannabinoid-
dependent inhibition of release in burst-firing neuron synapses
in vivo (Figure 5H). The b-neurexin KO did not change the relative
magnitude of the EPSC depression by WIN (Figures S5G and
S6B), likely because the enhanced basal CB1R activity is not
saturated by loss of b-neurexins. Together, these findings sug-
gest that the b-neurexin KO decreases excitatory synaptic
strength in burst-firing subiculum neurons, at least in part, by
enhancing tonic activation of CB1Rs in presynaptic terminals
of CA1 pyramidal neurons.expressing inactive (DCre) or active Cre-recombinase (Cre). (B) Representative
1, NR1 (an NMDAR subunit), and a-neurexins. (C and D) Immunocytochemistry
ere sparsely transfected with EGFP for visualization of neuronal morphology.
xin KO neurons (E), whereas anandamide is ineffective likely because it is only a
of mEPSC inter-event intervals (insets = mean frequencies). (Right) Summary
rescues decreased mini release in b-neurexin KO neurons. (Left) Experimental
ncies and amplitudes.
1R activation in b-neurexin KO neurons as measured by blocking CB1Rs with
epresentative traces. (Center) Cumulative distributions of mEPSC inter-event
G-induced changes in mEPSC frequencies.
are shown in graphs. Statistical analyses were with Student’s t test (*p < 0.05,
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Figure 5. Presynaptic KO of b-Neurexins in
CA1 Pyramidal Neurons Decreases Synap-
tic Strength at Burst-Firing Neuron Synap-
ses in the Subiculum
(A) Experimental design. (Left) Diagram of stereo-
tactic injections into the CA1 region. (Center)
Representative images of slices from stereo-
tactically injected mice at P35 to visualize AAV
infections (slices with <90% EGFP expression in
the CA1 region were rejected). (Right) Electro-
physiological recording configuration in acute
subiculum slices (Aoto et al., 2013).
(B) Identification of regular- and burst-firing pyra-
midal subiculum neurons in current-clamp mode.
(Left and Right) Representative traces. (Center)
Summary graph of the initial spiking frequency.
(C and D) Input/output (I/O) relations of AMPAR-
mediated EPSCs elicited by stimulation of CA1-
derived axons and recorded in regular- (C) or
burst-firing subiculum neurons (D). (Left) Summary
plots with representative traces on top. (Right)
Summary graphs of fitted linear input/output
slopes.
(E and F) Paired-pulse ratio (PPR) measurements
of AMPAR EPSCs in regular- (E) and burst-firing
subiculum neurons (F). (Left) Summary plots of
PPRs versus inter-stimulus intervals with repre-
sentative traces on top. (Right) Summary graphs of
PPRs at 100-ms inter-stimulus intervals.
(G) Only burst-firing, but not regular-firing, sub-
iculum neurons exhibit tonic endocannabinoid
signaling in wild-type mice. EPSCswere elicited at
0.1 Hz before and after bath application of the
CB1R antagonist AM251. (Left) Representative
EPSC traces. (Center) Plots of relative EPSC
amplitudes and AM251-induced EPSC amplitude
changes in individual neurons. (Right) Summary
graphs of AM251-induced EPSC amplitude
changes.
(H) Presynaptic b-neurexin KO increases tonic
endocannabinoid signaling in burst-firing sub-
iculum neurons. Experiments were performed
as in (G), except that burst-firing neurons were
analyzed in slices from b-neurexin cKO mice with
presynaptic expression of DCre- or Cre-EGFP in
the CA1 region (see A).
Data are means ± SEM; the numbers of neurons/
mice examined are shown in the summary graphs.
Statistical analysis was by paired Student’s t test
for single-cell plots and unpaired Student’s t test
for comparisons in other summary graphs (*p <
0.05; **p < 0.01; ***p < 0.001).
See also Figure S6.
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b-Neurexins Control Long-Term Plasticity in Burst-
Firing Neuron Synapses
In regular-firing neurons of the subiculum, LTP is induced by
postsynaptic activation of NMDARs, whereas in burst-firing neu-
rons LTP is induced by presynaptic activation of PKA (Wozny
et al., 2008; Behr et al., 2009). We asked whether LTP may
also be differentially affected by the presynaptic b-neurexin KO
in regular- and burst-firing neurons, similar to endocannabinoid
signaling. We observed no effect of the b-neurexin KO on LTP
in regular-firing neurons (Figure 6A). Strikingly, however, the
b-neurexin KO blocked LTP in burst-firing neurons (Figure 6B).
Presynaptic LTP in burst-firing neurons depends on adenylate
cyclase/PKA signaling (Wozny et al., 2008). Interestingly, CB1Rs
are coupled to Gai, which inhibits adenylate cyclase (Castillo
et al., 2012; Kano et al., 2009). Thus, we hypothesized that
enhanced basal CB1R activity caused by the b-neurexin KO
may contribute to, or even cause, the LTP impairment. To test
this hypothesis, we examined the effects of AM251 on LTP in
burst-firing subiculum neurons. AM251 had no effect on LTP
in control neurons (Figure 6C), but rescued the blocked LTP in
b-neurexin KO neurons (Figure 6D). To examine whether the
mechanism of CB1R activation by the b-neurexin KO in LTP
mirrors that of CB1R activation in release, we asked whether
postsynaptic inhibition of 2-AG synthesis also rescued the LTP
impairment in b-neurexin KO synapses. Indeed, selective intro-
duction of the 2-AG synthesis inhibitor U73122 into postsynaptic
patched neurons (Figure 4A) had no effect on LTP in control sli-
ces but fully rescued the block of LTP in b-neurexin KO slices
(Figures 6E and 6F). These results suggest that following the ge-
netic ablation of b-neurexins, tonic postsynaptic 2-AG synthesis
is enhanced and activates presynaptic CB1Rs, which impair this
form of LTP.
Deletion of b-Neurexins in CA1 Region Neurons Impairs
Contextual Fear Memory
To examine whether the function of b-neurexins in hippocampal
CA1 neurons is important for learning andmemory, we tested the
behavioral effects of deleting b-neurexins from the hippocampal
CA1 region (Figures 7A and 7B). We observed no changes in
the open-field behavior of mice, as measured quantitatively on
a force actometer (Figures 7C and S7A). We then performed
simultaneous cued and contextual fear conditioning. The CA1-
region-specific b-neurexin KO did not impair fear-learning acqui-
sition (Figure S7B), but strongly reduced freezing behavior when
themousewas placed in the context of the tone-foot-shock pair-
ings (Figure 7D). This phenotype was specific for contextual
memory since the b-neurexin KO had no effect on freezing in
response to an altered context or to the auditory cue, indicating
that contextual fear memory—which is known to be dependent
on hippocampal function (Fanselow and Dong, 2010)—is selec-
tively impaired by the b-neurexin KO (Figure 7D).
DISCUSSION
We analyzed triple-conditional KOmice that target all b-neurexin
genes in two preparations: cultured cortical neurons after condi-
tional KO of b-neurexins in vitro, and acute subiculum slices after
conditional presynaptic KO of b-neurexins in vivo. Our datademonstrate that b-neurexins regulate the strength and long-
term plasticity of a subset of excitatory synapses, that the b-neu-
rexin KO impairs presynaptic Ca2+ influx triggered by an action
potential in these synapses, and that presynaptic b-neurexins
control tonic postsynaptic endocannabinoid signaling mediated
by 2-AG (Figure 7D). Our in vivo results further suggest that
b-neurexins regulate neural circuits by modulating the strength
and plasticity of a subset of excitatory synapses via endocanna-
binoids and that this regulation is behaviorally important. Given
the complex nature of the many overlapping neural circuits
that ultimately guide behavior, it is perhaps not surprising that
the endocannabinoid-dependent modulation of synaptic circuits
is controlled by trans-synaptic cell-adhesion molecules, and that
this control is essential for the information processing capacity
of the brain. However, it is unexpected that b-neurexins as
relatively minor neurexin gene transcripts perform a pervasive
regulatory role in synapses, a role that adds to previously defined
other functions of neurexins (Missler et al., 2003; Aoto et al.,
2013, 2015).
In cultured cortical neurons in vitro, KO of b-neurexins
decreased the release probability at excitatory synapses
2-fold by causing a2-fold decrease in presynaptic Ca2+ tran-
sients (Figures 1F–1J, 2D, 2E, and 3A–3D). The magnitude of this
effect was surprising considering the low expression of b-neu-
rexins (Figure 1A) and the continued presence of the more abun-
dant a-neurexins. The underlying mechanism consisted, at least
in part, of an increase in tonic 2-AG endocannabinoid signaling,
as evidenced by the reversal of the release phenotype, both by
bath-application of the CB1R-antagonist AM251 (Figure 3G)
and by postsynaptic inhibition of 2-AG synthesis (Figure 4G).
Thus, b-neurexins appear to be selectively essential for regu-
lating excitatory synaptic strength via a control of tonic endocan-
nabinoid signaling.
In synapses formed by CA1-region pyramidal neurons onto
pyramidal neurons in the subiculum in vivo, the b-neurexin KO
also impaired excitatory synaptic transmission. We separately
examined synapses of regular- and burst-firing neurons, the
two types of subiculum pyramidal neurons (Staff et al., 2000;
vanWelie et al., 2006). The presynaptic b-neurexin KO produced
a decrease of excitatory synaptic strength in postsynaptic burst-
firing, but not regular-firing, neurons; this loss was reversed, at
least in part, by the CB1R antagonist AM251 (Figure 5). More-
over, only PKA-dependent presynaptic LTP in burst-firing, but
not NMDAR-dependent postsynaptic LTP in regular-firing, neu-
rons was impaired by the b-neurexin KO (Figures 6A and 6B).
Presynaptic LTP in presynaptic b-neurexin KO slices was
restored by inhibiting CB1Rs (Figures 6C and 6D) and, most
importantly, by postsynaptic inhibition of 2-AG synthesis in
burst-firing neurons (Figures 6E and 6F). The regulatory function
of presynaptic b-neurexins in release is likely physiologically
important since the b-neurexin KO in the CA1 region severely
impaired contextual fear conditioning (Figure 7).
To the best of our knowledge, our findings represent the
first description of trans-synaptic control of endocannabinoid
signaling by neurexins, complementing previous observations
of a role of postsynaptic neuroligin-3 in regulating the endo-
cannabinoid tone (Fo¨ldy et al., 2013). Tonic endocannabinoid
signaling at excitatory synapses has not previously beenCell 162, 593–606, July 30, 2015 ª2015 Elsevier Inc. 601
Figure 6. Presynaptic KO of b-Neurexins Selectively
Impairs LTP at Burst-Firing Subiculum Neurons by
Enhancing Basal Endocannabinoid Activity
(A) KO of b-neurexins does not change LTP of CA1 EPSCs
onto regular-firing subiculum neurons. LTP was induced by 4
3 100 Hz/1 s stimulation with 10-s intervals in current-clamp
mode at resting potential in acute slices from CA1-region-
specific b-neurexin KO mice obtained as described in Fig-
ure 5A. (Left) Representative traces. (Center) Average EPSC
amplitudes (1-min bins). (Right) Summary graphs of mean LTP
magnitude 50–60 min after induction.
(B) Same as in (A), except that burst-firing subiculum neurons
were analyzed.
(C and D) Same as in (B), except that the effect of the CB1R
antagonist AM251 on LTP was examined in slices from mice
injected with inactive Cre-recombinase (C) or with active
Cre-recombinase (D).
(E and F) Same as in (C) and (D), except that the effect of the
phospholipase C inhibitor U73122 introduced into the post-
synaptic neuron via the patch pipette was examined.
Data shown are means ± SEM; numbers of neurons/mice
examined are shown in the graphs. Statistical analysis was
performed by Student’s t test (*p < 0.05; **p < 0.01).
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documented, but anatomical evidence supports the presence of
DGL-a (which synthesizes the endocannabinoid 2-AG; Figure 4A)
and of CB1Rs at excitatory spine synapses in the hippocampus
(Katona et al., 2006; Kawamura et al., 2006). Moreover, several
studies showed that the CB1R-agonist WIN inhibits extracellular
stimulation-evoked glutamate release onto CA1 pyramidal neu-
rons (Hajos et al., 2001; Ohno-Shosaku et al., 2002; Kawamura
et al., 2006; Takahashi and Castillo, 2006). Excitatory synapses
onto CA1 pyramidal neurons exhibit evidence of phasic, but
not tonic, endocannabinoid signaling (Ohno-Shosaku et al.,
2002; Fo¨ldy et al., 2013), suggesting that the regulation of tonic
2-AG signaling by b-neurexins is synapse-specific and further
emphasizing how the identity of trans-synaptic neurexin com-
plexes can dictate function. No previous evidence has linked
endocannabinoid signaling to modulation of presynaptic LTP
of excitatory synapses, although CB1R activation has been
implicated in LTD (Peterfi et al., 2012; Han et al., 2012).
Mechanistically, the large effects of the b-neurexin KO in the
presence of the more abundant a-neurexins (Figures 1A and
S1) suggest that b-neurexins perform unique non-redundant
functions. The presynaptic action of b-neurexins (Figures 5
and 6), the SS4-dependence of the rescue (Figure 3E), and the
rescue of the presynaptic b-neurexin KO phenotype by blocking
postsynaptic synthesis of 2-AG (Figures 4 and 6) demonstrate
that the functions of b-neurexins involve trans-synaptic ligand in-
teractions. It is intriguing that some splice variants of neuroligin-1
only bind to b-neurexins, but not to a-neurexins (Figure S5I), and
that deletion of neuroligin-3 abolishes tonic endocannabinoid
signaling at inhibitory synapses of CCK basket cells (Fo¨ldy
et al., 2013). Although the b-neurexin KO led to the opposite ef-
fect at excitatory synapses on subiculum burst-firing neurons,
namely, an enhancement of basal endocannabinoid signaling,
it is possible that they are due to the same principal process:
trans-synaptic regulation of endocannabinoid signaling that
involves interactions of specific neurexin splice-variants with
particular neuroligin isoforms. Alternatively, it is possible that
as yet unknown b-neurexin-specific ligands mediate their func-
tions, or that a- and b-neurexins are localized to distinct synaptic
sites in a neuron.
The b-neurexin KO phenotype resembles that of neurexin-3
SS4 knockin mice in that both genetic manipulations reveal a
requirement for neurexins lacking an insert in SS4 (Figure 3E;
Aoto et al., 2013). However, the phenotypes of these mutations
are very different. While the b-neurexin KO caused a decrease
in presynaptic release probability and a loss of presynaptic
LTP without changes in postsynaptic parameters, the opposite
was observed in SS4 knockin mice expressing neurexin-3 with
constitutively spliced-in SS4 (Aoto et al., 2013). This difference
in phenotypes is likely due to the fact that the SS4 knockin af-
fects all a- and b-transcripts of ONE particular neurexin gene,
whereas the b-neurexin triple KO affects all b-transcripts, but
not a-transcripts, of all neurexin genes (which primarily express
a-neurexins). Thus, the only overlap between the two genetic
manipulations involves relatively small amounts of neurexin-3b
mRNAs. Any phenotypic overlap of these manipulations likely
would have been occluded by their more dramatic general phe-
notypes, although the small decrease in mEPSC amplitude and
AMPAR surface levels in b-neurexin KO synapses (Figures 3Aand S4F) may be due to the mechanism described by Aoto
et al. (2013) for the neurexin-3 SS4 knockin.
Independent of the molecular mechanism underlying the
selective functional role of b-neurexins in regulating excitatory
synaptic strength, this role likely has significant implications for
neural circuit dynamics (Figures 7A–7D). Information processing
by neural circuits involves continuous modulation of synaptic
strength at specific sites, such that the input/output relations
of a circuit depend on how action potentials are transformed
into synaptic signals that eventually cause firing—or inhibition
of firing—of the circuit output neurons. Endocannabinoids
have emerged as major regulators of circuit dynamics (Katona
and Freund, 2008; Castillo et al., 2012; Melis et al., 2014).
Thus, the control of endocannabinoid signaling by trans-synap-
tically acting b-neurexins, which in turn are regulated by alter-
native splicing, likely impacts circuit dynamics in many brain
regions. Understanding such dynamics will be essential for un-
derstanding behavior in general, and the conditional b-neurexin
KO mice provide a useful tool for region-specific modulation of
circuit dynamics in order to probe its behavioral relevance.
EXPERIMENTAL PROCEDURES
In all experiments, the researcher was blinded to the genetic manipulation. All
plasmids are available upon request, and themice described herewere depos-
ited in Jackson Labs for distribution. Brief experimental procedures are listed
here. For details, please see the Supplemental Experimental Procedures.
Mouse Generation and Husbandry
Neurexin-b-floxed (NBF) mice were generated by homologous recombination
targeting the 50 unique exon for each of the three b-neurexin genes that is not
shared with its a-neurexin counterparts. All procedures conformed to NIH
Guidelines for the Care and Use of Laboratory Animals and were approved
by the Stanford University Administrative Panel on Laboratory Animal Care.
mRNA Measurements
mRNA measurements were performed using qRT-PCR on RNA isolated from
P30 mouse brain tissues using the RNAqueous-Micro RNA Isolation Kit
(Invitrogen). Reactions for a- and b-neurexins and GAPDH (internal control)
were run with primers and probes as described in the Supplemental Experi-
mental Procedures.
Neuron Cultures
Cortical neurons were cultured from newborn NBF mice, infected on DIV 3–4
with lentiviruses, transfected using the calcium phosphate method when indi-
cated, and analyzed at DIV 14–16.
Virus Preparations
Nuclear localized EGFP-Cre and EGFP-DCre fusion proteins deliverable by
lentiviruses were from previously described vectors (Kaeser et al., 2011). All
neurexin-1b rescue constructs were previously described mouse cDNAs ex-
pressed from separate lentiviruses (Aoto et al., 2013). For in vivo infections,
we employed an AAV-DJ strain that is highly efficient in vivo as previously
described (Xu et al., 2012).
Stereotactic Injections
Stereotactic injections of AAVs were performed as previously described (Xu
et al., 2012). Efficiency and localization of AAV expression were confirmed
by fluorescence of nuclear EGFP encoded by the expressed inactive and
active EGFP-Cre-recombinase fusion proteins.
Ca2+ Imaging
A chimeric GCaMP5G-Syb2 was made and used in order to target GCaMP5G
calcium sensor to presynaptic terminals as described in the SupplementalCell 162, 593–606, July 30, 2015 ª2015 Elsevier Inc. 603
Figure 7. Conditional KO of b-Neurexins in the Hippocampal CA1 Region Impairs Contextual Memory: Model for b-Neurexin Action
(A) Design of behavioral experiments following Xu et al. (2012).
(B) Representative coronal images illustrating expression of Cre-EGFP in the CA1 region of the hippocampus after stereotactic injection (top) and zoomed CA1
image (bottom).
(C and D) Analysis of DCre- or Cre-injected mice in open-field (C) and fear conditioning tests (D). Open-field behavior (analyzed in three 5-min segments) was
quantified as spatial confinement (C, left), low-mobility bouts (C, center), and total distance traveled (C, right). Fear conditioning training exposed mice to three
30-s tones ending with 2-s electrical foot shocks separated by 1-min intervals (D; left, graphs, cumulative distributions; right, summary graphs, mean fear
conditioning memory as measured by freezing). Data are means ± SEM; the numbers of mice examined are shown in the graphs. Statistical analysis was
performed by Student’s t test (*p < 0.05).
(legend continued on next page)
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Experimental Procedures. Neuronal morphology was visualized by sparse
Ca2+- phosphate transfection with mCherry expression construct, and imag-
ing was performed on a Zeiss LSM 510 confocal microscope.
Electrophysiology
For details of electrophysiological recordings from cultured neurons and acute
slices, see the Supplemental Experimental Procedures.
Fear Conditioning
Fear conditioning and open-field behavioral analysis was essentially per-
formed as previously described (Xu et al., 2012).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2015.06.056.
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